1 |
Cremieux Pierre-Yves, Jarvinen Denise, Long Genia and Merrigan Phil : Pharmaceutical Spending and Health Outcomes. In : Sloan A. Frank, Hsieh Chee Ruey, eds. Pharmaceutical innovation : Incentives, Competition, and Cost-Benefit Analysis in International Perspective, New York : Cambridge University Press (2007).
|
2 |
Lichtenberg R. Frank : The impact of new drug launches on longevity : Evidence from longitudinal, disease-level data from 52 countries, 1982-2001. International Journal of Health Care Finance and Economics 5, 47 (2005).
|
3 |
Hsieh Chee Ruey, Vance Kuang Ta, Hong Yichen and Shih Ya- Chen Tina : Pharmaceutical Innovation and Health outcomes : Empirical evidence from Taiwan. In : Sloan A. Frank, Hsieh Chee Ruey, eds. Pharmaceutical innovation : Incentives, Competition, and Cost-Benefit Analysis in International Perspective, New York : Cambridge University Press (2007).
|
4 |
권혜영, 양봉민 : 신약도입에 다른 약품비 증가요인 분석. 보건경제와 정책연구 17(2) (2011).
|
5 |
보건복지부, 건강보험정책 관련 주요 참고자료 (2010.4).
|
6 |
건강보험심사평가원, www.hira.or.kr.
|
7 |
통계청 KOSIS www.kosis.or.kr 접속일자 2011년 4월 18일.
|
8 |
안두진 : SAS Proc Panel을 이용한 패널자료분석, 숭실대학교 석사학위논문.
|